Baseline characteristics and indicators at the hospital-level, median and IQR
| All admissions n=95 | Stroke n=92 | Heart failure n=93 | Acute myocardial infarction n=92 | Colorectal carcinoma n=93 | Total hip/knee arthroplasty for osteoarthritis n=73 | |
| Number of admissions (n) | 83 599 (50 048–138 284) | 1230 (753.3–17 953) | 1337 (874.5–1998.5) | 725.5 (349.3–1500) | 792 (549–1250.5) | 1521 (852–2248) |
| Age (years) | 52.3 (50.5–53.5) | 72.4 (71.5–73.5) | 77.4 (76.2–78.3) | 68.9 (66.1–70.2) | 69.8 (68.3–706) | 69.3 (68.0–70.2) |
| Male gender (%) | 45.0 (43.1–46.7) | 50.1 (51.5–48.3) | 49.0 (47.5–51.5) | 65.1 (61.6–68.3) | 53.9 (51.8–56.2) | 32.6 (29.8–34.7) |
| Charlson comorbidity score (%) | ||||||
| 0 | 88.9 (83.8–93.0) | 78.9 (66.3–86.0) | 61.7 (52.8–73.4) | 68.8 (56.3–78.1) | 78.3 (65.8–83.0) | 98.2 (94.4–99.3) |
| 1–2 | 7.7 (4.7–10.7) | 18.1 (12.2–27.4) | 5.1 (3.6–7.7) | 26.6 (19.3–35.3) | 19.9 (15.5–30.1) | 1.8 (0.7–5.4) |
| 3–4 | 0.6 (0.3–0.6) | 1.6 (0.6–3.3) | 0.3 (0.1–0.8) | 4.0 (0.5–6.9) | 2.0 (0.9–3.9) | 0 (0–0.1) |
| ≥5 | 2.9 (1.8–3.8) | 1.1 (0.6–1.7) | 31.2 (20.7–41.6) | 1.2 (0.5–1.9) | 0.5 (0.3–0.5) | 0 (0–0.1) |
| Urgent (%) | 54.0 (48.0–57.9) | 91.2 (84.4–95.0) | 87.9 (79.2–91.3) | 88.6 (80.9–94.2) | 22.6 (19.5–26.7) | 0.25 (0.1–0.7) |
| Indicators | ||||||
| In-hospital mortality (%) | 2.2 (2.0–4.5) | 14.6 (12.7–17.4) | 10.7 (9.3–12.5) | 8.0 (6.5–9.7) | 4.6 (3.6–5.8) | 0.10 (0.0–0.17) |
| Expected in-hospital mortality (%) | 2.2 (2.0–2.5) | 14.8 (8.3–8.9) | 11.2 (10.3–12.1) | 8.0 (7.1–9.2) | 4.6 (3.8–5.4) | 0.17 (0.16–0.18) |
| Standardised in-hospital mortality | 99.5 (90.6–106.0) | 97.8 (86.1–117.0) | 100.7 (87.6–112.3) | 98.6 (81.0–120.1) | 105.6 (80.3–127.7) | 80.1 (0.0–100.9) |
| Readmission survivors (%) | 7.8 (6.9–8.6) | 7.2 (6.0–8.3) | 14.6 (13.0–16.0) | 13.4 (11.3–15.2) | 11.5 (9.3–12.7) | 3.7 (2.9–4.3) |
| Expected readmission survivors (%) | 8.4 (8.0–8.8) | 8.6 (8.3–8.9) | 16.8 (15.8–17.3) | 15.9 (15.3–16.9) | 11.7 (11.0–12.5) | 3.7 (3.7–3.8) |
| Standardised readmission survivors | 93.7 (86.5–100.6) | 84.6 (69.9–94.3) | 86.5 (80.9–94.0) | 83.0 (68.8–93.8) | 96.9 (79.5–104.0) | 100.7 (75.4–114.8) |
| Upper quartile LOS survivors (%) | 23.4 (21.3–25.8) | 26.1 (23.1–31.2) | 25.3 (20.9–29.7) | 26.9 (20.2–33.0) | 25.4 (21.4–29.5) | 25.4 (17.3–38.1) |
| Expected upper quartile LOS survivors (%) | 24.1 (23.5–25.3) | 24.9 (23.8–25.8) | 26.2 (24.6–27.1) | 24.4 (22.5–26.2) | 24.9 (23.0–26.4) | 26.5 (25.3–27.1) |
| Standardised upper quartile LOS survivors | 95.7 (87.5–103.5) | 98.9 (92.5–125.7) | 98.2 (84.7–114.8) | 102.0 (86.5–128.3) | 104.1 (86.5–120.3) | 87.9 (64.9–137.9) |
LOS, length of stay.